Key Takeaways:
ASML trades at $1,740.99, roughly 50 percent below Bernstein's $2,623 Street-high target, after a China DUV headline triggered a 7 percent intraday drop.
"Ongoing AI-related investments and continued progress in AI technologies are driving demand for advanced Logic and Memory chips," CEO Christophe Fouquet said on the earnings call. "Our customers, in turn, continue to accelerate their capacity expansion plans."
The Dutch lithography supplier posted Q2 revenue of $10.65 billion, up 21.25 percent year over year, with EPS of $8.67 extending the beat streak to four straight quarters. Management raised full-year revenue guidance to €43 billion to €45 billion and plans to add 30 percent capacity to both low-NA EUV and DUV immersion for 2027.
The pullback traces to a July 27 Bloomberg report that a Chinese state-backed firm had begun mass-producing immersion DUV lithography tools. ASML fell more than 7 percent intraday, hitting its lowest level since early June, with ticker sentiment scores collapsing to -0.807. The stock has since recovered from a drawdown near $1,538, though it remains down 1.43 percent over the past month.
Bernstein's $2,623 target, carrying an Outperform rating, rests on four pillars: an absolute monopoly on EUV indispensable for sub-3nm nodes, aggressive High-NA adoption as leading foundries scale Gate-All-Around logic, an HBM capacity surge tied to accelerator roadmaps, and an expanding installed-base service line. Wells Fargo sits at $2,500 and Bank of America at $2,345, both echoing the same AI capex thesis.
Consensus across 44 analysts averages $2,178.04, roughly 25 percent above the current price. The ratings distribution: seven Strong Buy, 33 Buy, three Hold, one Sell. Year to date, ASML is up 63.53 percent, running well ahead of the S&P 500's 13.39 percent gain. The stock trades at a 38 forward P/E.
The wafer-fab-equipment group moved as a cohort during the July decline, but ASML's implied upside dwarfs its peers. Applied Materials is down 5.5 percent at $539.14 against a $629.06 average target, roughly 17 percent upside. Lam Research trades at $311.35 versus a $368.13 target for about 18 percent upside. KLA Corp has been hit hardest, down 10.43 percent at $198.11, with its $230.85 target implying roughly 17 percent upside.
JR Research moved to Buy the same day China headlines hit, arguing the forward multiple reset made the risk/reward more attractive. The bull case holds if AI capex keeps pulling forward, High-NA EUV adoption tracks Bernstein's ramp assumptions, and China DUV competition stays generations behind. The thesis weakens if Chinese domestic DUV closes the gap faster than expected, or if U.S. export rules widen enough to strand ASML's China revenue.
The guidance raise points to management's expectation that AI demand will accelerate through 2027. Investors will watch the next earnings call for updated segment margins and High-NA EUV order momentum.
This article is for informational purposes only and does not constitute investment advice.
